Literature DB >> 8615087

Charcot-Marie-Tooth disease type 1A: morphological phenotype of the 17p duplication versus PMP22 point mutations.

A A Gabreëls-Festen1, P A Bolhuis, J E Hoogendijk, L J Valentijn, E J Eshuis, F J Gabreëls.   

Abstract

Charcot-Marie-Tooth disease type 1A (CMT1A) or hereditary motor and sensory neuropathy type Ia (HMSN type Ia) is an autosomal dominant demyelinating polyneuropathy, which may result from duplications as large as 1.5 Mb on chromosome 17p 11.2-p12 encompassing the gene for the peripheral myelin protein PMP22, or from point mutations in this gene. In general, it is not possible to distinguish, by clinical and neurophysiological criteria, the cases associated with the duplication mutation from those associated with point mutations of the PMP22 gene, although the latter tend to be more severe. In this study we demonstrated that the two genotypes exhibit different morphological characteristics. In the PMP22 duplicated cases the mean g-ratio (axon diameter versus fibre diameter) is significantly lower than normal, while in cases of PMP22 point mutations nearly all myelinated fibers have an extremely high g-ratio. In cases with point mutations, onion bulbs are abundantly present from an early age, whereas onion bulbs in the duplicated cases develop gradually in the first years of life. Increase in total transverse fascicular area is most pronounced in the point mutation cases. The differences in pathology between these two very different types of mutations involving the same gene likely reflect differences in pathogenesis and may offer clues in understanding the function of PMP22.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8615087     DOI: 10.1007/bf00318579

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  27 in total

1.  The status of HMSN type III.

Authors:  A A Gabreëls-Festen; F J Gabreëls; F G Jennekens; T W Janssen-van Kempen
Journal:  Neuromuscul Disord       Date:  1994-01       Impact factor: 4.296

2.  Changes of the ratio between myelin thickness and axon diameter in the human developing sural nerve.

Authors:  J M Schröder; J Bohl; K Brodda
Journal:  Acta Neuropathol       Date:  1978-08-07       Impact factor: 17.088

3.  Early morphological features in dominantly inherited demyelinating motor and sensory neuropathy (HMSN type I).

Authors:  A A Gabreëls-Festen; E M Joosten; F J Gabreëls; F G Jennekens; T W Janssen-van Kempen
Journal:  J Neurol Sci       Date:  1992-02       Impact factor: 3.181

4.  Allelic heterogeneity in hereditary motor and sensory neuropathy type Ia (Charcot-Marie-Tooth disease type 1a).

Authors:  J E Hoogendijk; E A Janssen; A A Gabreëls-Festen; G W Hensels; E M Joosten; F J Gabreëls; I Zorn; L J Valentijn; F Baas; B W Ongerboer de Visser
Journal:  Neurology       Date:  1993-05       Impact factor: 9.910

5.  Regulation of tissue-specific expression of alternative peripheral myelin protein-22 (PMP22) gene transcripts by two promoters.

Authors:  U Suter; G J Snipes; R Schoener-Scott; A A Welcher; S Pareek; J R Lupski; R A Murphy; E M Shooter; P I Patel
Journal:  J Biol Chem       Date:  1994-10-14       Impact factor: 5.157

6.  Prevalence of the 1.5-Mb 17p deletion in families with hereditary neuropathy with liability to pressure palsies.

Authors:  E C Mariman; A A Gabreëls-Festen; S E van Beersum; L J Valentijn; F Baas; P A Bolhuis; P J Jongen; H H Ropers; F J Gabreëls
Journal:  Ann Neurol       Date:  1994-10       Impact factor: 10.422

7.  Identical point mutations of PMP-22 in Trembler-J mouse and Charcot-Marie-Tooth disease type 1A.

Authors:  L J Valentijn; F Baas; R A Wolterman; J E Hoogendijk; N H van den Bosch; I Zorn; A W Gabreëls-Festen; M de Visser; P A Bolhuis
Journal:  Nat Genet       Date:  1992-12       Impact factor: 38.330

8.  Gene dosage is a mechanism for Charcot-Marie-Tooth disease type 1A.

Authors:  J R Lupski; C A Wise; A Kuwano; L Pentao; J T Parke; D G Glaze; D H Ledbetter; F Greenberg; P I Patel
Journal:  Nat Genet       Date:  1992-04       Impact factor: 38.330

9.  Charcot-Marie-Tooth disease type 1A. Association with a spontaneous point mutation in the PMP22 gene.

Authors:  B B Roa; C A Garcia; U Suter; D A Kulpa; C A Wise; J Mueller; A A Welcher; G J Snipes; E M Shooter; P I Patel; J R Lupski
Journal:  N Engl J Med       Date:  1993-07-08       Impact factor: 91.245

10.  Qualitative and quantitative morphology of human sural nerve at different ages.

Authors:  J M Jacobs; S Love
Journal:  Brain       Date:  1985-12       Impact factor: 13.501

View more
  24 in total

1.  Soluble neuregulin-1 modulates disease pathogenesis in rodent models of Charcot-Marie-Tooth disease 1A.

Authors:  Robert Fledrich; Ruth M Stassart; Axel Klink; Lennart M Rasch; Thomas Prukop; Lauren Haag; Dirk Czesnik; Theresa Kungl; Tamer A M Abdelaal; Naureen Keric; Christine Stadelmann; Wolfgang Brück; Klaus-Armin Nave; Michael W Sereda
Journal:  Nat Med       Date:  2014-08-24       Impact factor: 53.440

Review 2.  A review of genetic counseling for Charcot Marie Tooth disease (CMT).

Authors:  Carly E Siskind; Seema Panchal; Corrine O Smith; Shawna M E Feely; Joline C Dalton; Alice B Schindler; Karen M Krajewski
Journal:  J Genet Couns       Date:  2013-04-21       Impact factor: 2.537

3.  Nerve conduction velocity in CMT1A: what else can we tell?

Authors:  F Manganelli; C Pisciotta; M M Reilly; S Tozza; A Schenone; G M Fabrizi; T Cavallaro; G Vita; L Padua; F Gemignani; M Laurà; R A C Hughes; A Solari; D Pareyson; L Santoro
Journal:  Eur J Neurol       Date:  2016-07-14       Impact factor: 6.089

4.  Myelin abnormality in Charcot-Marie-Tooth type 4J recapitulates features of acquired demyelination.

Authors:  Bo Hu; Megan McCollum; Vignesh Ravi; Sezgi Arpag; Daniel Moiseev; Ryan Castoro; Bret Mobley; Bryan Burnette; Carly Siskind; John Day; Robin Yawn; Shawna Feely; Yuebing Li; Qing Yan; Michael Shy; Jun Li
Journal:  Ann Neurol       Date:  2018-03-30       Impact factor: 10.422

5.  Experienced fatigue in facioscapulohumeral dystrophy, myotonic dystrophy, and HMSN-I.

Authors:  J S Kalkman; M L Schillings; S P van der Werf; G W Padberg; M J Zwarts; B G M van Engelen; G Bleijenberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-10       Impact factor: 10.154

6.  Development of early postnatal peripheral nerve abnormalities in Trembler-J and PMP22 transgenic mice.

Authors:  A M Robertson; C Huxley; R H King; P K Thomas
Journal:  J Anat       Date:  1999-10       Impact factor: 2.610

7.  Abnormal Schwann cell/axon interactions in the Trembler-J mouse.

Authors:  A M Robertson; R H King; J R Muddle; P K Thomas
Journal:  J Anat       Date:  1997-04       Impact factor: 2.610

Review 8.  The PMP22 gene and its related diseases.

Authors:  Jun Li; Brett Parker; Colin Martyn; Chandramohan Natarajan; Jiasong Guo
Journal:  Mol Neurobiol       Date:  2012-12-07       Impact factor: 5.590

9.  PMP22 expression in dermal nerve myelin from patients with CMT1A.

Authors:  Istvan Katona; Xingyao Wu; Shawna M E Feely; Stephanie Sottile; Carly E Siskind; Lindsey J Miller; Michael E Shy; Jun Li
Journal:  Brain       Date:  2009-05-15       Impact factor: 13.501

10.  Shortened internodal length of dermal myelinated nerve fibres in Charcot-Marie-Tooth disease type 1A.

Authors:  Mario A Saporta; Istvan Katona; Richard A Lewis; Stacey Masse; Michael E Shy; Jun Li
Journal:  Brain       Date:  2009-12       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.